Biomarin Pharmaceutical reported $617.14M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 94.64M 172.32M
Acceleron Pharma XLRN:US $ 336.46M 0.26M
Acorda Therapeutics ACOR:US $ 36.17M 9.55M
Agios Pharmaceuticals AGIO:US $ 400.22M 568.9M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
Alnylam Pharmaceuticals ALNY:US $ 1093.99M 348.22M
Amgen AMGN:US $ 11969M 5339M
Arena Pharmaceuticals ARNA:US $ 386.65M 127.52M
Bayer BAYN:GR € 4316M 927M
Biogen BIIB:US $ 1541.8M 200.2M
Biomarin Pharmaceutical BMRN:US $ 617.14M 24.39M
Bluebird Bio BLUE:US $ 402.46M 48.99M
Gilead Sciences GILD:US $ 6837M 1944M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Insmed INSM:US $ 846.56M 81.77M
Intercept Pharmaceuticals ICPT:US $ 428.77M 283.15M
IONIS PHARMACEUT IONS:US $ 1987M 1421.88M
Moderna Inc MRNA:US 5.55B 53M
Neurocrine Biosciences NBIX:US $ 311.1M 56.9M
Ptc Therapeutics PTCT:US $ 189.82M 12.47M
Puma Biotechnology PBYI:US $ 63.95M 25.9M
Regeneron Pharmaceuticals REGN:US $ 3432.4M 1360.2M
Sangamo Biosciences SGMO:US $ 176.95M 7.08M
Sarepta Therapeutics SRPT:US $ 1599.11M 98.16M
Seattle Genetics SGEN:US $ 685.17M 271.74M
Ultragenyx Pharmaceutical RARE:US $ 197.54M 93.34M
United Therapeutics UTHR:US $ 908.5M 33.7M
Vertex Pharmaceuticals VRTX:US $ 6275.7M 212.02M
YTE INCY:US $ 1999.02M 201.44M